Dengue immunity can protect against Zika virusNovember 13, 2017
LA JOLLA, CA -- Manifestations of Zika virus (ZIKV) infection differ drastically. Sometimes they are catastrophic, most notably when they cause microcephaly in some babies born to infected mothers. At other times, they are mild and fleeting, suggesting that unknown factors temper Zika infections' severity. Recently, dengue virus emerged as a prime suspect because it shares many genetic and structural characteristics with ZIKV and is endemic in most of the regions affected by Zika's global spread.
A study published the November 13, 2017, issue of Nature Communications by La Jolla Institute for Allergy and Immunology (LJI) investigator Sujan Shresta, Ph.D., now addresses interplay between dengue and ZIKV infections. It reports that mice rendered immune to dengue show "cross-protection" from subsequent Zika infection and then identifies specific types of immune T-cells capable of defending against both viruses. These revelations have profound implications for efforts to build a potent anti-Zika vaccine.
"In some parts of the world Zika is almost like a secondary infection. It has spread into Brazil/Latin America and is moving into places in Asia where people previously had dengue," says Shresta, an associate professor in LJI's Center for Infectious Disease. "Our new work suggests that vaccines targeting either virus could be engineered to induce both T cell and antibody responses effective to protect people in these areas."
When one encounters a pathogen in real life, two arms of the immune system spring into action to neutralize it. In the so-called humoral response, B-cells begin to secrete specific antibody proteins, which latch onto and neutralize pathogens in tissue or blood. Simultaneously, a cell-mediated immunity system also becomes active, deploying cytotoxic T-cells to directly recognize and kill pathogen-infected cells.
In theory, the ideal vaccine might mimic both antibody and T cell responses to block an infectious disease. But in truth, most (26 of 28 vaccines currently licensed for human use) stimulate primarily a B-cell or antibody response, which in many cases is sufficient. But Shresta's new work confirms what many vaccinologists are beginning to suspect, namely that protection against thus far intractable pathogens will likely require rallying both B-cells and T-cells.
Specifically, Shresta's team created the first "sequential" mouse model mimicking dengue-then-Zika infection. To do that, they first infected mice genetically vulnerable to to this family of viruses with dengue virus. Those mice became sick, recovered from infection, and hence acquired immunity to dengue, presumably because viral infection had mobilized their immune B-cells, T-cells or both. The group then inoculated the same mice with ZIKV and waited to see if mice showed ZIKV symptoms. But overall, mice that had previously acquired dengue immunity showed protection against Zika, as evidenced by a reduced burden of ZIKV in blood and tissues, such as brain, liver or testis, compared to control mice not "pre-inoculated" against dengue.
"These experiments suggest that the reason that some people infected with Zika do not come down with disease is due to prior exposure to dengue," says Shresta. "This may explain why Zika is not passed to the unborn child of every pregnant woman in dengue-endemic countries exposed to virus."
In a different experiment, the scientists isolated cytotoxic T cells from the blood of dengue-immune mice and infused them into normal mice, a procedure known as adoptive T-cell transfer. When infused mice were then infected with ZIKV, they also showed disease resistance, supporting the idea that the T-cell arm of the immune system can do the heavy lifting against ZIKV infection.
Jinsheng Wen, Ph.D., a professor at Wenzhou Medical University in Wenzhou City, China, was the study's first author. Wen says the results from this work are a powerful lesson to vaccinologists currently wrestling with how to design an effective Zika vaccine: "Our work strongly suggests that a successful vaccine would need to include components to induce not only a B-cell response but also a T-cell response." Today, anti-dengue vaccines that primarily evoke antibody responses are in clinical trials or starting to be licensed in certain countries but show only moderate success. And, there are no approved Zika vaccines, although the US government is partnering with pharmaceutical companies to develop candidates.
Shresta hopes work like hers will guide those efforts. "Approved vaccines for many diseases work by inducing antibody responses. But now we are dealing with problematic diseases, like dengue and Zika for which we cannot rely solely on raising antibodies. Certain pathogens are likely to also require a T-cell response."
The study was funded by NIAID/NIH grants 1R01 AI116813 (S.S.), and R01 AI104972 and P01 AI106695 (to M.S.D.) and by institutional support (S.S.) from the La Jolla Institute for Allergy & Immunology.
About the La Jolla Institute for Allergy and Immunology
The La Jolla Institute for Allergy and Immunology is dedicated to understanding the intricacies and power of the immune system to that we may apply that knowledge to promote human health and prevent a wide range of human diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advanced leading toward its goal: life without disease.
La Jolla Institute for Allergy and Immunology
Related Infectious Disease Articles:
A study, published in the American Journal of Respiratory and Critical Care Medicine, describes a new treatment pathway for antibiotic resistant bacteria and infectious diseases with benefits for patients and health care providers.
Researchers at Penn State have received $2.35 million from the National Science Foundation to study disease transmission among animals with a goal of better predicting outbreaks of infectious diseases within humans.
The American Association for the Advancement of Science (AAAS) has selected Kacey Ernst, Ph.D., M.P.H., associate professor of epidemiology in the University of Arizona Mel and Enid Zuckerman College of Public Health, as a 2017-2018 Public Engagement Fellow.
The world remains 'grossly underprepared' for outbreaks of infectious disease, which are likely to become more frequent in the coming decades, warn a team of international experts in The BMJ today.
In a study appearing in the Nov. 22/29 issue of JAMA, Heidi E.
The delay between the time when a disease outbreak becomes possible and when it actually happens depends chiefly on how frequently infection is introduced to the population and how quickly the number of cases caused by a single individual increases, according to new research from the University of Georgia.
A unique 21-year study of more than 2.4 million cases of infectious disease across Australia reveals a major social divide where being poorer, living remotely or being an Indigenous Australian means having an increased risk of sexually transmissible infections.
Infectious disease experts nationwide will gather in New Orleans for the 5th annual IDWeek Oct.
University of Colorado Cancer Center researcher shows that mothers who contract malaria during pregnancy may have children with increased risk of Burkitt's lymphoma.
Less than fifty percent of HIV-infected patients achieve viral suppression in medically underserved areas.
Related Infectious Disease Reading:
Infectious Diseases: Pharmacology & Therapeutics
by Dr Erick A Bourassa (Author)
This book covers both the basic pharmacology and clinical pharmacotherapy of infectious diseases. All of the available pharmacotherapies used in the treatment of infectious diseases including antibiotics, antimycobacterials, antifungals, anthelminthics, antiprotozoals, antivirals, and immunizations are included in this text. Inside, you will find: -A thorough description of the mechanism of action, spectrum of coverage, common and serious adverse effects, and mechanisms of resistance to each drug group. -Clinical indications and contraindications of each drug as well as guideline-directed... View Details
Infectious Diseases A Clinical Short Course 3/E (In Thirty Days Series)
by Frederick S. Southwick (Author)
LEARN THE PRINCIPLES OF CLINICAL INFECTIOUS DISEASESIN JUST THIRTY DAYS
A Doody's Core Title for 2017!
Infectious Diseases: A Clinical Short COURSE is a concise overview of this important field designed to help the busy physician, medical student, nurse practitioner, and physician assistant to understand, diagnose, and treat common infectious diseases. This unique self-instruction book is organized by system/region as opposed to pathogens―simulating how common pathogens anddisorders would be encountered in rounds or in practice.
By indicating the... View Details
The Infectious Disease Colouring Book:: A Gruesome Colouring Therapy Adventure
by MR Nicholas Wright (Author)
A Beautiful disgusting Coloring BookNEW: JUNE 2016
You've never experienced anything like this before. This adult coloring book features 35+ coloring pages featuring ORIGINAL ARTWORK of infectious diseases.Each page is designed with beautiful illustrations and is printed on one side so you can color away and save your gruesome pictures. Diseases include:LeprosyFlesh-eating bacteria
And many more!
This is an original book and is perfect for adults who want to amuse themselves or their loved ones. Also the... View Details
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: 2-Volume Set, 8e
by John E. Bennett MD MACP (Author), Raphael Dolin MD (Author), Martin J. Blaser MD (Author)
After thirty five years, Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases, 8th Edition is still the reference of choice for comprehensive, global guidance on diagnosing and treating the most challenging infectious diseases. Drs. John E. Bennett and Raphael Dolin along with new editorial team member Dr. Martin Blaser have meticulously updated this latest edition to save you time and to ensure you have the latest clinical and scientific knowledge at your fingertips. With new chapters, expanded and updated coverage, increased worldwide perspectives, and many new... View Details
The Woman with a Worm in Her Head: And Other True Stories of Infectious Disease
by Pamela Nagami M.D. (Author), F. Gonzalez-Crussi (Foreword)
A normal, healthy woman becomes host to a pork tapeworm that is burrowing into her brain and disabling her motor abilities.
A handsome man contracts Chicken Pox and ends up looking like the victim of a third degree burn.
A vigorous young athlete is bitten by an insect and becomes a target for flesh-eating strep.
Even the most innocuous everyday activities such as eating a salad for lunch, getting bitten by an insect, and swimming in the sea bring human beings into contact with dangerous, often deadly microorganisms. In The Woman with a Worm in Her Head, Dr.... View Details
Mandell, Douglas and Bennett’s Infectious Disease Essentials, 1e (Principles and Practice of Infectious Diseases)
by John E. Bennett MD MACP (Author), Raphael Dolin MD (Author), Martin J. Blaser MD (Author)
Brought to you by the expert editor team from Principles and Practice of Infectious Diseases, this brand-new handbook provides a digestible summary of the 241 disease-oriented chapters contained within the parent text. Boasting an exceptionally templated design with relevant tables and illustrations, it distills the essential, up-to-date, practical information available in infectious disease. This high-yield manual-style reference will prove useful for a wide variety of practitioners looking for quick, practical, and current infectious disease... View Details
Oxford Handbook of Infectious Diseases and Microbiology (Oxford Medical Handbooks)
by Estée Török (Author), Ed Moran (Author), Fiona Cooke (Author)
Fully reviewed and revised for its second edition, the Oxford Handbook of Infectious Diseases and Microbiology maintains its position as the must-have guide to all aspects of infectious diseases and microbiology. Reflecting the current approach to joint postgraduate training programmes, the handbook takes an integrated approach to both subjects. It covers the basic principles of bacteriology and virology, along with specific guidance on individual diseases and conditions, all in the accessible Oxford Handbook style.
Now including new topics on important subjects such as... View Details
Infectious Disease: A Very Short Introduction (Very Short Introductions)
by Benjamin Bolker (Author), Marta Wayne (Author)
As doctors and biologists have learned, to their dismay, infectious disease is a moving target: new diseases emerge every year, old diseases evolve into new forms, and ecological and socioeconomic upheavals change the transmission pathways by which disease spread. By taking an approach focused on the general evolutionary and ecological dynamics of disease, this Very Short Introduction provides a general conceptual framework for thinking about disease.
Ecology and evolution provide the keys to answering the "where", "why", "how", and "what" questions about any particular... View Details
Harrison's Infectious Diseases, Third Edition (Harrison's Specialty)
by Dennis L. Kasper (Author), Anthony S. Fauci (Author)
Infectious Diseases – as only Harrison’s can cover them
A Doody's Core Title for 2017!
Featuring a superb compilation of chapters related to infectious diseases derived from Harrison’s Principles of Internal Medicine, Nineteenth Edition (including content from the acclaimed Harrison’s DVD, now available here in print), this concise, full-color clinical companion delivers the latest knowledge in the field backed by the scientific rigor and authority that have defined Harrison’s. You will find 137... View Details
Infectious Diseases: Colour Guide (Colour Guides)
by Peter Ball FRCPEd (Author), James A. Gray FRCPEd (Author)
A concise, up-to-date manual of clinical infectious diseases. Features a brief discussion of over 40 illnesses and includes a photographic record of conditions that were once common but are now rapidly decreasing in order to aid in their recognition and diagnosis. The 2nd Edition is completely revised and updated to include new clinical photographs and the latest information on treatment and immunization. View Details